EP0562796A1 — Phenoxyacetic acid compounds and medical preparations containing them
Assigned to Terumo Corp · Expires 1993-09-29 · 33y expired
What this patent protects
Disclosed are phenoxyacetic acid compounds of formula (I): where X is a hydrogen atom, a lower alkyl group or a halogen atom; R1 is a carboxyl group or a lower alkoxycarbonyl group; Y is an oxygen atom, or n is an integer of from 0 to 5; Z is …
USPTO Abstract
Disclosed are phenoxyacetic acid compounds of formula (I): where X is a hydrogen atom, a lower alkyl group or a halogen atom; R1 is a carboxyl group or a lower alkoxycarbonyl group; Y is an oxygen atom, or n is an integer of from 0 to 5; Z is or R2 is a hydrogen atom or a lower alkyl group; and m is 0 or 1. The compounds and their physiologically acceptable salts are used as thromboxane A2 antagonistic agents, leukotriene antagonistic agents and/or anti-allergic agents.
Drugs covered by this patent
- Bevyxxa (BETRIXABAN) · Portola Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.